SGCIA
AGN

Smith Graham & Co Investment Advisors’s Allergan plc AGN Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-35,270
Closed -$4.45M – 136
2013
Q2 		$4.45M Buy
+35,270
New +$3.99M 0.69% 64

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Smith Graham & Co Investment Advisors's AGN Position: Q3 2013 in Review

Smith Graham & Co Investment Advisors sold out of Allergan plc (AGN) in Q3 2013, closing a stake of 35,270 shares — an estimated $4.45M sold.

Smith Graham & Co Investment Advisors first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $4.45M in Q2 2013. 479 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Smith Graham & Co Investment Advisors reported no remaining Allergan plc position as of Q3 2013 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 35,270 Allergan plc shares in Q3 2013, an estimated $4.45M.
  • Smith Graham & Co Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 1 quarter.
  • Smith Graham & Co Investment Advisors's Allergan plc position peaked at $4.45M in Q2 2013.
  • 479 funds tracked by Wall St. Rank held Allergan plc as of Q3 2013.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q3 2013, filed 16 Oct 2013.